Pharmaceutical properties of fluticasone propionate nasal drops: A new formulation

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 53, 1999, Pages 17-20

  Denyer, S ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE;

DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; INTRANASAL DRUG ADMINISTRATION; NOSE POLYP; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG PACKAGING; DRUG STABILITY; HUMANS; NASAL POLYPS;

EID: 0032799391     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Report of the second meeting of the parties to the Montreal Protocol on substances that pollute the ozone layer. United Nations Environmental Protection (UNEP) Organization. London, 27-29 June 1990.
2. Denyer SP, Wallhäuser K-H. Antimicrobial preservatives and their properties. In: Denyer SP, Baird R, editors. Guide to microbiological control in pharmaceuticals. Chichester: Ellis Norwood, 1990:251-273.
3. Hodges NA, Denyer SP, Hanlon GW, Reynolds JP. Preservative efficacy tests in formulated nasal products: reproducibility and factors affecting preservative activity. J Pharm Pharmacol 1996;48:1237-1242.
4. Hoffmann T, Wolf G, Koidl B. Effect of topical corticosteroids and topical antihistamines on ciliary epithelium of human nasal mucosa in vitro. HNO 1998;46:146-151.
5. Berg OH, Lie K, Steinsvag SK. The effects of topical nasal corticosteroids on rat respiratory mucosa in vivo with special reference to bcnzalkonium chloride. Allergy 1997;52:627-632.
6. Gallagher G, MacKay I. Doctors and drops. BMJ 1991;303:761.
7. Diestelhorst M, Kwan KA, Suverlerup R. Dose uniformity of ophthalmic suspensions. J Cataract Refract Surg 1998;24:672-677.
8. Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by sprays and drops. J Pharm Pharmacol 1985;37:294-297.
9. Royal Pharmaceutical Society of Great Britain. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain, 1997.